MORE►
Alzheimer’s research
Photo: UNT Health Fort Worth
UNT Health FW Gets $6.8M for Alzheimer’s Study on Adults With Down Syndrome
by Sandra Engelland | May 28, 2026
Studies show the lifetime incidence of Alzheimer’s disease among adults with Down syndrome is 90%. Researchers called the national ABC-DS study "especially timely" as more treatment options for Alzheimer’s disease are found and more clinical trials are launched for adults with Down syndrome.
Fort Worth’s Rainwater Charitable Foundation Awards $600K to 2 Neurodegenerative Disease Researchers
by David Seeley |
Feb 6, 2025
The foundation's annual Rainwater Prizes honor researchers worldwide who are advancing discoveries for diseases caused by tau protein accumulations in the brain. This year's winners include a professor at the University of Gothenburg in Sweden and an Early-Career Scientist honoree at Brown University.
MORE►
by Sandra Engelland |
Mar 16, 2021
Contracting Alzheimer's is the No. 1 fear of people over 65, says Sid O'Bryant, who wants to give primary physicians the ability to test for Alzheimer's with a blood test. That can offer peace of mind to many and earlier help for those who need it.
His groundbreaking research, which has revealed significant differences in biomarkers for the disease, could make the treatment of Alzheimer's more like that for cancer—a multi-dimensional "precision" approach.
His groundbreaking research, which has revealed significant differences in biomarkers for the disease, could make the treatment of Alzheimer's more like that for cancer—a multi-dimensional "precision" approach.
MORE►
by Alex Edwards |
Dec 9, 2020
The University of North Texas Health Science Center is recruiting 1,000 African Americans from North Texas to participate in its HABLE study for Alzheimer’s research, which tends to focus solely on non-Latino whites.
MORE►
